Cephalon Inc

Indeed, Ambit raised $50 million in November 2012 on the strength of the quizartinib Phase II data, despite the fact that an earlier, less specific candidate from Cephalon Inc

Cephalon Inc.'s forigerimod has a novel mechanism of action

The findings suggested quizartinib was a far cry from an earlier FLT3 compound, lestaurtinib, which fizzled in summer 2009 for Cephalon Inc., of Frazer, Pa

was on the first-to-invent system, a company that was the first to file a patent in another country wasn't always eligible for the patent in the U.S. Fed Circuit Gives Enablement Guidance While Cephalon Inc

In that study, the product was found to accelerate neutrophil and platelet recovery, with high 100-day patient survival and low rates of graft-vs.-host disease (GVHD). (See BioWorld Today, July 8, 2011.) In 2010, Mesoblast inked a $350 million strategic alliance with Cephalon Inc. (now part of Teva Pharmaceutical Industries Ltd.) to develop and commercialize its MPC therapeutics for hematopoietic stem cell transplantation in cancer patients and other indications. (See BioWorld Today, Dec. 9

In that study, the product was found to accelerate neutrophil and platelet recovery, with high 100-day patient survival and low rates of graft-vs.-host disease (GVHD). (See BioWorld Today, July 8, 2011.) In 2010, Mesoblast inked a $350 million strategic alliance with Cephalon Inc. (now part of Teva Pharmaceutical Industries Ltd.) to develop and commercialize its MPC therapeutics for hematopoietic stem cell transplantation in cancer patients and other indications. (See BioWorld Today, Dec. 9

Vivitrol Cephalon Inc

Cephalon Inc. buyout in 2011; original developer was ChemGenex Pharmaceuticals Ltd.) Synribo Omecataxine mepesuccinate

The companies hope the FLT3 inhibitor, which has come out of a Phase II study with high marks, will succeed where an earlier, less specific candidate from Cephalon Inc

It was acquired in the Jerusalem-based big pharma's $6.8 billion acquisition of Cephalon Inc

It was acquired in the Jerusalem-based big pharma's $6.8 billion acquisition of Cephalon Inc

It was acquired in the Jerusalem-based big pharma's $6.8 billion acquisition of Cephalon Inc

Lundbeck licensed Canadian rights to Treanda last year from Cephalon Inc., of Frazer, Pa., a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd

The deal's structure is not unlike that of the 2004 merger of privately held ChemGenex Therapeutics Inc., of Menlo Park, Calif., and Australia's AGT Biosciences Ltd., listed on the ASX, to form a biotech with two cancer drugs in clinical trials, Garner said. (See BioWorld Today, April 28, 2004.) The successor firm, ChemGenex Pharmaceuticals Ltd., of Melbourne, was acquired in 2011 for $231 million in cash by Cephalon Inc., which was subsequently nabbed by Jerusalem's Teva Pharmaceutical

Tullman started his career at GlaxoSmithKline plc, where he was exposed to finance, sales, marketing and R&D. He subsequently co-founded and managed several biotechs, including Ception Therapeutics Inc., which was developing an asthma drug when it was acquired in 2010 by Cephalon Inc., and Trigenesis Therapeutics Inc., a dermatology company that licensed the dermatology assets of SkyePharma plc and was quickly acquired by Dr. Reddy's Laboratories Ltd. (See BioWorld Today, Feb. 24, 2010, and

The deal's structure is not unlike that of the 2004 merger of privately held ChemGenex Therapeutics Inc., of Menlo Park, Calif., and Australia's AGT Biosciences Ltd., listed on the ASX, to form a biotech with two cancer drugs in clinical trials, Garner said. (See BioWorld Today, April 28, 2004.) The successor firm, ChemGenex Pharmaceuticals Ltd., of Melbourne, was acquired in 2011 for $231 million in cash by Cephalon Inc., which was subsequently nabbed by Jerusalem's Teva Pharmaceutical

Lundbeck licensed Canadian rights to Treanda last year from Cephalon Inc., of Frazer, Pa., a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd

The FDA also approved Mylan's ANDA for a generic version of Provigil (modafinil, Cephalon Inc